Jpmorgan Chase & Co »

Lisata Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Lisata Therapeutics (LSTA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Lisata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lisata Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lisata Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $50 16 3.13
2023-12-31 $30 11 2.73
2023-09-30 $17 8 2.13

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Lisata Therapeutics

BML Capital Management
Vanguard Group
BlackRock
Geode Capital Management
Cook Wealth Management Group
Dimensional Fund Advisors
Susquehanna International
HighTower Advisors
Bank of America Corporation
Morgan Stanley
Tower Research Capital
Founders Capital Management
Wells Fargo & Company
Royal Bank of Canada
Jpmorgan Chase & Co

View all funds holding Lisata Therapeutics